Serum levels of tumor associated trypsin inhibitor (TATI) and glomerular filtration rate

Renal Failure

Volumn 20, Issue 2, 1998, Pages 295-302

  Tramonti, Gianfranco ^a,c   Ferdeghini, Marco ^b   Donadio, Carlo ^a   Annichiarico, Carmela ^b   Norpoth, Maria ^a   Bianchi, Romano ^b   Bianchi, Clandio ^a  

^a Clinica Medica 2   (Italy)

^b Istituto di Medicina Nucleare   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Glomerular filtration rate; Low molecular weight proteins

Indexed keywords

APROTININ;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; ISOELECTRIC POINT; KIDNEY CLEARANCE; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031900397     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045114     Document Type: Article

References (33)

1. Maack T, Hvung Park C, Camargo MJF: Renal filtration, transport and metabolism of proteins. In: Seldini DW and Giebish G (eds); The Kidney: Physiology and Pathophysiology, 2nd ed. New York, Raven Press, 1992, pp 3005-3038.
2. 2M and lysozyme in renal disease. Scand J Urol Nephrol 6:249-256, 1972.
3. Sturfelt G, Truedsson L, Thysell H, Björk H: Serum level of complement factor D in systemic lupus erythematosus-an indicator of glomerular filtration rate. Acta Med Scand 216:171-177, 1984.
4. 2M as a measure of glomerular filtration rate. Acta Med Scand 218:499-503, 1985.
5. 1M and its relationship to renal function. Nephron 41:320-324, 1985.
6. 2M levels in patients with renal insufficiency. Am J Kidney Dis 13:70-74, 1989.
7. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, Grubb A: Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 40:1921-1926, 1994.
8. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP: Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int 47:312-318, 1995.
9. 2M: Its significance in the evaluation of renal function. Kidney Int 32:635-641, 1987.
10. 1M radioiodée augmente chez le rat mononéphrectomisé. Nephrologie 13:221-225, 1992.
11. 131I-Lysozyme in the uninephrectomized rat. Contrib Nephrol 101:85-91, 1993.
12. th International Congress of Nephrology. Jerusalem, Israel, June 13-18, 1993, p 554.
13. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 51:2-15, 1997.
14. Stenman U-H, Huhtala M-L, Koistinen R, Seppala M: Immunochemical demonstration of an ovarian cancer - associated urinary peptide. Int J Cancer 30:53-57, 1982.
15. Stenman U-H, Koivunen E, Itkonen O: Biology and function of tumor-associated trypsin inhibitor, TATI. Scand J Clin Lab Invest 51 (Suppl. 207):5-9, 1991.
16. Huhtala M-L, Pesonen K, Kalkkinen N, Stenman U-H: Purification and characterization of a tumorassociated trypsin inhibitor from the urine of a patient with ovarian cancer. J Biol Chem 257:13713-13716, 1982.
17. Halila H, Huhtala M-L, Schröder T, Kiviluoto T, Stenman U-H: Pancreatic secretory trypsin inhibitor in pancreatectomized patients. Clin Chem Acta 153:209-216, 1985.
18. Lasson A, Borgström A, Ohlsson K: Elevated pancreatic secretory trypsin inhibitor levels during severe inflammatory disease, renal insufficiency, and after various surgical procedures. Scand J Gastroenterol 21:1275-1280, 1986.
19. Piantino P, Mosso R, Polloni R, Cerchier A, Gennaretti G, Daziano E: Dosaggin del tumor associated trypsin inhibitor (TATI) in soggetti con malattie gastrointestinali. Minerva Medica 80:199-203, 1989.
20. Stenman U-H, Ballesta A, and Torre GC, eds: Clinical evaluation of tumor-associated trypsin inhibitor (TATI) Scand J Clin Lab Invest 51 (Suppl. 207):5-73, 1991.
21. Kuopio T, Ekfors TO, Nikkanen V, Mevalainen TJ: Acinar cell carcinoma of the pancreas. Report of three cases. APHIS 103:69-78, 1995.
22. Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttila I, Alhava E: Tumor-associated trypsin inhibitor in the diagnosis of pancreatic carcinoma. J Cancer Res Clin Oncol 120:494-497, 1994.
23. Pasanen P, Eskelinen M, Kulju A, Penttila I, Janatuinen E, Alhava E: Tumor-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242. Scand J Clin Lab Invest 55:119-124, 1995.
24. Larbre H, Deltour M, Marechal F, Deltour G: Comparison of a new tumor Marker, TATI, to other tumor markers in various cancers. Journal of Tumor Marker Oncology 5:305-311, 1990.
25. Meria P, Toubert ME, Cussenot O, Bassi S, Janssen T, Desgrandchamps F, Cortesse A, Schlageter MH, Teillac P, Le Duc A: Tumour-associated trypsin inhibitor and renal cell carcinoma. Eur Urol 27:223-226, 1995.
26. Banfi G, Murone M, Slaviero G: High Concentration of tumor-associated trypsin inhibitor in hemodialyzed patients. Clin Chem 34:174-175, 1988.
27. Tramonti G, Ferdeghini M, Donadio C, Annichiarico C, Bianchi R, Bianchi C: Serum concentration of five markers (TATI, TPA, TPS, CYFRA 21-1, SCC) and renal function in man. In: Carpi A, Sagripanti A, Grassi B (eds); Advances in Management of Malignancies. Cosenza, Editoriale Bios, 1993, pp 47-49.
28. Tramonti G, Donadio C, Ferdeghini M, Annichiarico C, Norpoth X, Bianchi R, Bianchi C: Serum tumor - associated trypsin inhibitor (TATI) and renal function. Scand J Clin Lab Invest 56 653-656, 1996.
29. 131I-labeled human growth hormone of high specific radioactivity. Biochem J 89:114-123, 1963.
30. 99mTc. Nephron 24:174-178, 1979.
31. Bianchi C, Donadio C, Tramonti G, Aimer I, Lorusso P, Deleide G, Lunghi F, Vannucci C, Vitali S, Ricchiuti V, Guzzardi R: High and preferential accumulation in the kidney of anionic and cationic small proteins. Contrib Nephrol 83:39-46, 1990.
32. Mitch WE, Collier VU, Walser M: Creatinine Metabolism in chronic renal failure. Clin Sci 58:327-335, 1980.
33. 2M: the constant chain of HLA-antigens. Eur J Clin Invest 10:293-300, 1980.